Tumor-mediated immunosuppression is a challenge in cancer treatment A. A. Hakim Guest Editorial Pages: 1 - 6
Improvement of monocyte chemotaxis with BCG immunotherapy in acute lymphoblastic leukemia: Comparison of chemotherapy versus chemotherapy plus immunotherapy as therapeutic regimens D. A. NorrisW. L. WestonLorrie F. Odom Original Articles Pages: 15 - 18
Studies of lymphocyte stimulation to tumor-associated antigen J. A. RothD. L. Morton Original Articles Pages: 19 - 23
Studies of lymphocyte stimulation to tumor-associated antigen J. A. RothD. O. CheeD. L. Morton Original Articles Pages: 25 - 29
Immunoprophylaxis with attenuated ehrlich ascites tumor cells in admixture with BCG R. Turcotte Original Articles Pages: 31 - 35
Hypothesis: Non-hodgkin lymphomas are abnormal immune responses J. A. Habeshaw Original Articles Pages: 37 - 42
Peptides as requirement for immunotherapy of the guinea-pig line-10 tumor with endotoxins E. RibiR. ParkerM. B. Goren Original Articles Pages: 43 - 58
Tumour-associated antigens in culture medium of malignant melanoma cell strains R. JacubovichJ.-F. Doré Original Articles Pages: 59 - 64
Spontaneous cell-mediated cytotoxicity (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in peripheral blood and draining lymph nodes of patients with mammary carcinoma W. HeidenreichK. JaglaH. Deicher Original Articles Pages: 65 - 69